Attorney Paul d'Oliveira Hails Consumer Advocacy Group's Decision to Urge the FDA to Immediately Remove Victoza from the Market due to Renewed Pancreatic Cancer Concerns

Share Article

This April, the consumer-advocacy group, Public Citizen, petitioned The U.S. Food and Drug Administration (FDA) to immediately remove Victoza from the market due to concerns about the drug's carcinogenetic side-effects. In support of it's proposed ban, the group points to studies linking Victoza to an increased risk of its users developing pancreatic cancer or pancreatitis.

Attorney Paul d’Oliveira stated that “this is just another of far too many examples where the Big Pharmaceutical Industry continues to put profits ahead of people. Why should a Consumer Advocacy Group have to urge the FDA to remove a dangerous drug from the market? Should not the people who produce the drug have enough human decency to look at the science and decide on their own that the drug should be pulled from the market until the science is clear on whether or not the drug causes an increased risk of cancer? The reason is all too clear to me and this issue is clear in this next election…Do we want to elect politicians who get big contributions from corporations and who are loyal to them? The only way things are going to change is if people make better choices in the voting booths. The Courts are already stacked with Right Wing judges as our present Supreme Court has shown by its recent decisions about generic drugs and the Super Pacs being allowed to donate as much money as they want for a candidate. People need to know that all that is left to promote change is their votes in these upcoming elections as this country is clearly now the best country money can buy. And the only thing that can change it is to get rid of these present politicians who are backed by the big corporations. Otherwise, the rich will continue to get richer and the middle class and poor will continue to see their standard of living diminished.”

Developed by Novo Nordisk as a treatment for Type-2 Diabetes, Victoza, or "liraglutide," belongs to a class of medications known as "Glucagon-like Peptide-1" (GLP-1). These types of drugs work by mimicking the GLP-1 hormone and trigger the production of insulin from the pancreas when a patient's blood sugar is low. This process commonly results in the inflammation of a patient's pancreas which leads to an increased risk of developing pancreatitis and pancreatic cancer. Public Citizen claims that the chance of survival for those patients whose pancreatic cancer has spread after five years is 1.8%.

Public Citizen noted that the risk of developing Pancreatitis was four times greater for Victoza patients than patients on similar diabetes medications. Additionally, the group recorded 28 times more instances of Victoza patients developing pancreatic cancer than patients on similar diabetic medications. In its 17 month long study since Victoza, the study yielded 200 cases of Victoza patients developing acute pancreatitis while estimating the number of patients who have suffered painful and severe side effects to be approximately 2000.

Public Citizen states that the FDA's historic response to Victoza's side effects is not enough. It points to the FDA's decision in 2009 that required warnings of thyroid tumor and cancer after significant links were established between those side effects and Victoza use. Additionally, on separates occasions the FDA had to renew Victoza's warning label requirements to include the continually updating list of side effects including a recent warning for severe allergic reactions. Director of Public Citizen's Health Research Group, Dr. Sidney Wolfe, states that by urging the FDA to remove Victoza completely, the group seeks to put an end to the commonplace FDA strategy of merely requiring additional warnings with the hope "that physicians and patients will pay attention," and expects the FDA adopts a more proactive approach to combating these severe and deadly side effects.



Aside from Victoza's link to pancreatitis and pancreatic cancer, the drug's maker, Norvo Nordisk, acknowledges side effects including, but not limited, to thyroid tumor and cancer, headaches, nausea, heartburn, exhaustion, and irregular appetite.

If you or a loved one has developed pancreatitis, pancreatic cancer, thyroid cancer or tumors, or any of the number of side effects associated with the use of Victoza, the attorneys at d'O'liveira & Associates want you to know that you may be entitled to compensation. Working with the leading dangerous drug lawyers, our attorneys will provide you the legal representation you deserve to handle you claim.

For a free legal consultation, call 1-800-992-6878 or visit their website at Victoza Lawsuit Lawyer

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Paul d'Oliveira
Visit website